1. Li, Changlin, Jiang, Wencong, Hu, Qingting, Liu, Chang-Bai, Li, Benyi. . Enhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis. In Oncotarget, 7, 22893-910. doi:10.18632/oncotarget.8290. https://pubmed.ncbi.nlm.nih.gov/27014974/
2. Li, Benyi, Li, Changlin. . Suppression of Prostate Cancer Metastasis by DPYSL3-Targeted saRNA. In Advances in experimental medicine and biology, 983, 207-216. doi:10.1007/978-981-10-4310-9_15. https://pubmed.ncbi.nlm.nih.gov/28639202/
3. Matsunuma, Ryoichi, Chan, Doug W, Kim, Beom-Jun, Malovannaya, Anna, Ellis, Matthew J. 2018. DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer. In Proceedings of the National Academy of Sciences of the United States of America, 115, E11978-E11987. doi:10.1073/pnas.1810598115. https://pubmed.ncbi.nlm.nih.gov/30498031/
4. Kwon, Kisang, Song, Ji-Hye, Park, Hyewon, Kwon, O-Yu, Kim, Seung-Whan. . Regulation of Dihydropyrimidinase-like 3 Gene Expression by MicroRNAs in PC12 Cells with Induced Ischaemia and Hypothermia. In Folia biologica, 69, 69-73. doi:10.14712/fb2023069020069. https://pubmed.ncbi.nlm.nih.gov/38063003/
5. Oya, Hisaharu, Kanda, Mitsuro, Sugimoto, Hiroyuki, Fujiwara, Michitaka, Kodera, Yasuhiro. 2014. Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor. In Journal of gastroenterology, 50, 590-600. doi:10.1007/s00535-014-0993-4. https://pubmed.ncbi.nlm.nih.gov/25173447/
6. Blasco, Hélène, Bernard-Marissal, Nathalie, Vourc'h, Patrick, Andres, Christian R, Corcia, Philippe. 2013. A rare motor neuron deleterious missense mutation in the DPYSL3 (CRMP4) gene is associated with ALS. In Human mutation, 34, 953-60. doi:10.1002/humu.22329. https://pubmed.ncbi.nlm.nih.gov/23568759/
智鼠故事 
